Hologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside? Both HOLX and Myriad Genetics are longstanding key players in the Molecular Diagnostics space. But which one is a better…
Hologic Q1 Earnings Beat, Stock Falls on Dismal 25 Sales Guidance HOLXs fiscal 2025 first-quarter results reflect the strength of its Molecular Diagnostics business.…
Should You Retain Hologic Stock in Your Portfolio Now? HOLXs strength in the Molecular Diagnostics wing instills optimism among investors. Yet, macro woes and currency impacts raise concerns.…
Is HOLX Stock a Smart Hold for Your Portfolio Right Now? Hologics strength in Molecular Diagnostics is highly promising. Yet, macroeconomic uncertainties can pose headwinds for its operations.…